63 related articles for article (PubMed ID: 22133206)
1. Acute hyperinsulinemia is followed by increased serum concentrations of fibroblast growth factor 23 in type 2 diabetes patients.
Winther K; Nybo M; Vind B; Pedersen SM; Højlund K; Rasmussen LM
Scand J Clin Lab Invest; 2012 Apr; 72(2):108-13. PubMed ID: 22133206
[TBL] [Abstract][Full Text] [Related]
2. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
[TBL] [Abstract][Full Text] [Related]
3. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.
Anderwald C; Anderwald-Stadler M; Promintzer M; Prager G; Mandl M; Nowotny P; Bischof MG; Wolzt M; Ludvik B; Kästenbauer T; Pacini G; Luger A; Krebs M
Diabetes Care; 2007 Sep; 30(9):2374-80. PubMed ID: 17595351
[TBL] [Abstract][Full Text] [Related]
4. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
5. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
Burén J; Lindmark S; Renström F; Eriksson JW
Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
[TBL] [Abstract][Full Text] [Related]
6. Acute hyperinsulinemia decreases plasma osteoprotegerin with diminished effect in type 2 diabetes and obesity.
Jørgensen GM; Vind B; Nybo M; Rasmussen LM; Højlund K
Eur J Endocrinol; 2009 Jul; 161(1):95-101. PubMed ID: 19380455
[TBL] [Abstract][Full Text] [Related]
7. Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes.
Nogueira JP; Maraninchi M; Béliard S; Padilla N; Duvillard L; Mancini J; Nicolay A; Xiao C; Vialettes B; Lewis GF; Valéro R
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1039-44. PubMed ID: 22308041
[TBL] [Abstract][Full Text] [Related]
8. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
Weber TJ; Liu S; Indridason OS; Quarles LD
J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance of protein metabolism in type 2 diabetes.
Pereira S; Marliss EB; Morais JA; Chevalier S; Gougeon R
Diabetes; 2008 Jan; 57(1):56-63. PubMed ID: 17940118
[TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
11. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
12. Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation.
Hansen J; Rinnov A; Krogh-Madsen R; Fischer CP; Andreasen AS; Berg RM; Møller K; Pedersen BK; Plomgaard P
Diabetes Metab Res Rev; 2013 Sep; 29(6):463-72. PubMed ID: 23564759
[TBL] [Abstract][Full Text] [Related]
13. Are the glycemic and insulinemic index values of carbohydrate foods similar in healthy control, hyperinsulinemic and type 2 diabetic patients?
Lan-Pidhainy X; Wolever TM
Eur J Clin Nutr; 2011 Jun; 65(6):727-34. PubMed ID: 21427735
[TBL] [Abstract][Full Text] [Related]
14. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
15. Normal FGF23 levels in adult idiopathic phosphate diabetes.
Laroche M; Boyer JF; Jahafar H; Allard J; Tack I
Calcif Tissue Int; 2009 Feb; 84(2):112-7. PubMed ID: 19148564
[TBL] [Abstract][Full Text] [Related]
16. The interrelation between FGF23 and glucose metabolism in humans.
Ursem SR; Vervloet MG; Büttler RM; Ackermans MT; Oosterwerff MM; Eekhoff EMV; Lips P; Serlie MJ; la Fleur SE; Heijboer AC
J Diabetes Complications; 2018 Sep; 32(9):845-850. PubMed ID: 29996975
[TBL] [Abstract][Full Text] [Related]
17. Effects of euglycemic hyperinsulinemia and lipid infusion on circulating cholecystokinin.
Weickert MO; Möhlig M; Spranger J; Schöfl C; Loeffelholz CV; Riepl RL; Otto B; Pfeiffer AF
J Clin Endocrinol Metab; 2008 Jun; 93(6):2328-33. PubMed ID: 18364380
[TBL] [Abstract][Full Text] [Related]
18. Changes in cytokine levels during acute hyperinsulinemia in offspring of type 2 diabetic subjects.
Ruotsalainen E; Stancáková A; Vauhkonen I; Salmenniemi U; Pihlajamäki J; Punnonen K; Laakso M
Atherosclerosis; 2010 Jun; 210(2):536-41. PubMed ID: 20031127
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia.
Hojman P; Pedersen M; Nielsen AR; Krogh-Madsen R; Yfanti C; Akerstrom T; Nielsen S; Pedersen BK
Diabetes; 2009 Dec; 58(12):2797-801. PubMed ID: 19720803
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-α agonist treatment.
Mráz M; Lacinová Z; Kaválková P; Haluzíková D; Trachta P; Drápalová J; Hanušová V; Haluzík M
Physiol Res; 2011; 60(4):627-36. PubMed ID: 21574752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
